|
|
SPOT ON
|
|
Editorials, studies, guidelines: How much dependency on industry can be tolerated?
|
|
|
NEW ON THE MARKET
|
|
Transdermal rotigotine (NEUPRO) for Parkinson's disease
Parkinson's disease: Initial therapy with levodopa or dopamine agonists?
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
MOSES-study with eprosartane (EMESTAR,. TEVETEN) - What is the value of angiotensin-II-receptor antagonists in hypertension
|
|
|
IN BRIEF
|
|
Anti-arrhythmic drugs for atrial fibrillation
Influenza: Do neuraminidase inhibitors reduce mortality?
Homocysteine: - Vitamin cocktail with B6, B12, and folic acid again without benefit
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Diplopia with oseltamivir
|
|
|
SIDE EFFECTS
|
|
Abuse potential of the antiepileptic pregabalin (LYRICA)
|
|